VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Technology Scientific & Technical Instruments

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by allinenergy2on Jun 26, 2015 1:09pm

141 Views

Post# 23872786

RE:RE:RE:everybody can say what you want

That's it. After reading that post I bailed. Got rid of all my 500 shares. Thanks for the great input eunice and billboredmonkey.

Great product, but if docs have to beg on hands and knees, and still can't get hospitals to buy even after FDA approval, then I just can't stick around to experience such agony.

Good luck to all here, including the beggars.

eunice12 - (6/25/2015 4:07:47 PM)
RE:RE:everybody can say what you want
1. Yes opening it up is encouraging.
2. What to make of the value of the part below is not possible though "All of the recent developments have occurred years ahead of schedule, with some advances previously thought impossible. .." I mean, these are serious roadblocks they removed, however are there others, or is the path clearly outlined for investors now? Problem is we weren't aware of these issues when GA stated docs were "begging" for the product, so "begging" was just a terse play on words, and should have said "We aspire to remove all roadblocks so docs will beg for the product - some roadblocks may be impossible to remove."